BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 15324403)

  • 21. Metastatic glucagonoma: treatment with liver transplantation.
    Radny P; Eigentler TK; Soennichsen K; Overkamp D; Raab HR; Viebahn R; Mueller-Horvart C; Sotlar K; Rassner G
    J Am Acad Dermatol; 2006 Feb; 54(2):344-7. PubMed ID: 16443073
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Glucagonoma syndrome without diabetes mellitus].
    Mikkelsen CS; Mikkelsen DB; Vestergaard V; Clemmensen O; Nielsen HO; Bygum A
    Ugeskr Laeger; 2008 Nov; 170(47):3876. PubMed ID: 19014744
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 73-year-old man with hyperglycemia, skin rashes, anemia and weight loss.
    Henry JG; Xue N; Kinder BK; Inzucchi SE
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2428-33. PubMed ID: 8675556
    [No Abstract]   [Full Text] [Related]  

  • 24. Rare presentation of endocrine pancreatic tumour: a case of glucagonoma without necrolytic migratory erythema?
    Manes G; Pellegrini A; Riccardi F; Uomo G
    Ital J Gastroenterol; 1995 Jun; 27(5):248-9. PubMed ID: 8541575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Necrolytic migratory erythema with myelodysplastic syndrome without glucagonoma.
    Technau K; Renkl A; Norgauer J; Ziemer M
    Eur J Dermatol; 2005; 15(2):110-2. PubMed ID: 15757825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Glucagonoma revealed by necrolytic migratory erythema].
    Bonaventure C; Merle P; Grezard P; Ruiz JM; Chevallier M; Scoazec JY; Trepo C
    Gastroenterol Clin Biol; 2003 Feb; 27(2):230-2. PubMed ID: 12658134
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Necrolytic migratory erythema as the only presenting sign of a glucagonoma.
    Johnson SM; Smoller BR; Lamps LW; Horn TD
    J Am Acad Dermatol; 2003 Aug; 49(2):325-8. PubMed ID: 12894090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The glucagonoma syndrome and necrolytic migratory erythema: a clinical review.
    van Beek AP; de Haas ER; van Vloten WA; Lips CJ; Roijers JF; Canninga-van Dijk MR
    Eur J Endocrinol; 2004 Nov; 151(5):531-7. PubMed ID: 15538929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Papulosquamous eruption with weight loss: Necrolytic migratory erythema (glucagonoma syndrome).
    Skouge JW; Farmer ER
    Arch Dermatol; 1985 Mar; 121(3):400, 403. PubMed ID: 2983618
    [No Abstract]   [Full Text] [Related]  

  • 30. [Necrolytic cutaneous erythema and pancreatic tumour: the glucagonoma].
    Drematcheff S; Champetier de Ribes TL; Marty C; Sans N; Railhac JJ
    J Radiol; 2004 Mar; 85(3):329-31. PubMed ID: 15192527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Necrolytic migratory erythema: unresolved problems in diagnosis and pathogenesis. A case report and literature review.
    Kasper CS
    Cutis; 1992 Feb; 49(2):120-2, 125-8. PubMed ID: 1563284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Images in clinical medicine. Necrolytic migratory erythema.
    McGevna L; Tavakkol Z
    N Engl J Med; 2010 Jan; 362(1):e1. PubMed ID: 20054043
    [No Abstract]   [Full Text] [Related]  

  • 33. Glucagonoma syndrome: survival 24 years following diagnosis.
    Nightingale KJ; Davies MG; Kingsnorth AN
    Dig Surg; 1999; 16(1):68-71. PubMed ID: 9949270
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Necrolytic migratory erythema associated with glucagonoma syndrome: a case report.
    Dal Coleto CC; de Mello AP; Piquero-Casals J; Lima FR; Vilela MA; Festa-Neto C; Sanches JA
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(6):183-8. PubMed ID: 11836542
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Necrolytic migratory erythema, presenting as candidiasis, due to a pancreatic glucagonoma.
    Katz R; Fischmann AB; Galotto J; Guccio JG; Higgins GA; Ortega LG; West WH; Recant L
    Cancer; 1979 Aug; 44(2):558-63. PubMed ID: 476569
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dermatitis, glossitis, stomatitis, cheilitis, anemia and weight loss: a classic presentation of pancreatic glucagonoma.
    Povoski SP; Zaman SA; Ducatman BS; McFadden DW
    W V Med J; 2002; 98(1):12-4. PubMed ID: 11941895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Necrolytic migratory erythema: the outermost marker for glucagonoma syndrome.
    Gantcheva ML; Broshtilova VK; Lalova AI
    Arch Dermatol; 2007 Sep; 143(9):1221-2. PubMed ID: 17875900
    [No Abstract]   [Full Text] [Related]  

  • 38. Cystic glucagonoma: A rare variant of an uncommon neuroendocrine pancreas tumor.
    Brown K; Kristopaitis T; Yong S; Chejfec G; Pickleman J
    J Gastrointest Surg; 1998; 2(6):533-6. PubMed ID: 10457311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagonoma syndrome: case report and literature review.
    Parker CM; Hanke CW; Madura JA; Liss EC
    J Dermatol Surg Oncol; 1984 Nov; 10(11):884-9. PubMed ID: 6092443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What is your diagnosis? Necrolytic migratory erythema associated with a glucagonoma.
    Chaw L; Krop TM; Hood AF
    Cutis; 2008 Jan; 81(1):25, 30-2. PubMed ID: 18306843
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.